2018 Oct;44(10):1902-1908
Despite its reputation, BPC-157 is still classified for research use only and has not been approved by the FDA for medical treatments
the protocol therefore front-loads frequency and holds the dose fixed
Follow-up: When B12 therapy is initiated, you must check your energy state and nerve symptoms as well as laboratory measurements of B12, MMA, and homocysteine to determine progress
In my experience, BPC-157 is especially useful for acute and subacute injuries where the goal is to reduce pain, calm local tissue irritation, support healing, and help the patient tolerate rehabilitation and progressive loading more effectively
One proposed mechanism is that SNAC temporarily associates with drug molecules, increasing their lipophilicity and making it easier for them to cross biological membranes